{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:19:46Z","timestamp":1792405186052,"version":"4.4.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T00:00:00Z","timestamp":1473292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T00:00:00Z","timestamp":1473292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","award":["Grant-in-Aid for Scientific Research (B) (26293175)"],"award-info":[{"award-number":["Grant-in-Aid for Scientific Research (B) (26293175)"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["Highway Program for Realization of Regenerative Medicine"],"award-info":[{"award-number":["Highway Program for Realization of Regenerative Medicine"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00535-016-1258-1","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T05:38:02Z","timestamp":1473313082000},"page":"129-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Status of and candidates for cell therapy in liver cirrhosis: overcoming the \u201cpoint of no return\u201d in advanced liver cirrhosis"],"prefix":"10.1007","volume":"52","author":[{"given":"Shuji","family":"Terai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunori","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,8]]},"reference":[{"key":"1258_CR1","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/hep.26359","volume":"57","author":"BA Runyon","year":"2013","unstructured":"Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651\u20133.","journal-title":"Hepatology"},{"key":"1258_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.23258","volume":"51","author":"RS O\u2019Shea","year":"2010","unstructured":"O\u2019Shea RS, Dasarathy S, McCullough AJ, et al. Alcoholic liver disease. Hepatology. 2010;51:307\u201328.","journal-title":"Hepatology"},{"issue":"61","key":"1258_CR3","first-page":"642","volume":"2014","author":"American Association for the Study of Liver Diseases, European Association for the Study of the Liver","year":"2014","unstructured":"American Association for the Study of Liver Diseases, European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol. 2014;2014(61):642\u201359.","journal-title":"J Hepatol"},{"key":"1258_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2010.03.001","volume":"53","author":"European Association for the Study of the Liver","year":"2010","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397\u2013417.","journal-title":"J Hepatol"},{"key":"1258_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00535-016-1216-y","volume":"51","author":"H Fukui","year":"2016","unstructured":"Fukui H, Saito H, Ueno Y, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016;51:629\u201350.","journal-title":"J Gastroenterol"},{"key":"1258_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1053\/j.gastro.2013.11.034","volume":"146","author":"MJ Williams","year":"2014","unstructured":"Williams MJ, Clouston AD, Forbes SJ. Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology. 2014;146:349\u201356.","journal-title":"Gastroenterology"},{"key":"1258_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/ncb3203","volume":"17","author":"WY Lu","year":"2015","unstructured":"Lu WY, Bird TG, Boulter L, et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol. 2015;17:971\u201383.","journal-title":"Nat Cell Biol"},{"key":"1258_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.27099","volume":"60","author":"A Tsuchiya","year":"2014","unstructured":"Tsuchiya A, Lu WY, Weinhold B, et al. Polysialic acid\/neural cell adhesion molecule modulates the formation of ductular reactions in liver injury. Hepatology. 2014;60:1727\u201340.","journal-title":"Hepatology"},{"key":"1258_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/gut.2010.224436","volume":"60","author":"YN Kallis","year":"2011","unstructured":"Kallis YN, Robson AJ, Fallowfield JA, et al. Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response. Gut. 2011;60:525\u201333.","journal-title":"Gut"},{"key":"1258_CR10","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/hep.24315","volume":"53","author":"JA Thomas","year":"2011","unstructured":"Thomas JA, Pope C, Wojtacha D, et al. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology. 2011;53:2003\u201315.","journal-title":"Hepatology"},{"key":"1258_CR11","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/hep.20452","volume":"40","author":"I Sakaida","year":"2004","unstructured":"Sakaida I, Terai S, Yamamoto N, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology. 2004;40:1304\u201311.","journal-title":"Hepatology"},{"key":"1258_CR12","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/hep.27723","volume":"61","author":"JW Jang","year":"2015","unstructured":"Jang JW, Choi JY, Kim YS, et al. Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis. Hepatology. 2015;61:1809\u201320.","journal-title":"Hepatology"},{"key":"1258_CR13","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","volume":"373","author":"MP Curry","year":"2015","unstructured":"Curry MP, O\u2019Leary JG, Bzowej N, et al. Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis. N Engl J Med. 2015;373:2618\u201328.","journal-title":"N Engl J Med"},{"key":"1258_CR14","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1016\/j.jhep.2015.02.040","volume":"62","author":"SJ Forbes","year":"2015","unstructured":"Forbes SJ, Gupta S, Dhawan A. Cell therapy for liver disease: From liver transplantation to cell factory. J Hepatol. 2015;62:S157\u201369.","journal-title":"J Hepatol"},{"key":"1258_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","volume":"5","author":"RM Merion","year":"2005","unstructured":"Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant. 2005;5:307\u201313.","journal-title":"Am J Transplant"},{"key":"1258_CR16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64:830\u201341.","journal-title":"Gut"},{"key":"1258_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jhbp.245","volume":"22","author":"E Seki","year":"2015","unstructured":"Seki E, Brenner DA. Recent advancement of molecular mechanisms of liver fibrosis. J Hepatobiliary Pancreat Sci. 2015;22:512\u20138.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1258_CR18","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/apt.13620","volume":"43","author":"M Noureddin","year":"2016","unstructured":"Noureddin M, Anstee QM, Loomba R. Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2016;43:1109\u201323.","journal-title":"Aliment Pharmacol Ther"},{"key":"1258_CR19","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan D, Kim YO. Evolving therapies for liver fibrosis. J Clin Invest. 2013;123:1887\u2013901.","journal-title":"J Clin Invest"},{"issue":"224\u201331","key":"1258_CR20","first-page":"e1","volume":"11","author":"DC Rockey","year":"2013","unstructured":"Rockey DC. Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies. Clin Gastroenterol Hepatol. 2013;11(224\u201331):e1\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1258_CR21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3748\/wjg.v21.i3.742","volume":"21","author":"S Berardis","year":"2015","unstructured":"Berardis S, Dwisthi Sattwika P, Najimi M, et al. Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects. World J Gastroenterol. 2015;21:742\u201358.","journal-title":"World J Gastroenterol"},{"key":"1258_CR22","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2013.08.174","volume":"65","author":"G Serviddio","year":"2013","unstructured":"Serviddio G, Bellanti F, Vendemiale G. Free radical biology for medicine: learning from nonalcoholic fatty liver disease. Free Radic Biol Med. 2013;65:952\u201368.","journal-title":"Free Radic Biol Med"},{"key":"1258_CR23","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675\u201385.","journal-title":"N Engl J Med"},{"key":"1258_CR24","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/hep.24281","volume":"53","author":"YH Paik","year":"2011","unstructured":"Paik YH, Iwaisako K, Seki E, et al. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2\/gp91phox mediate hepatic fibrosis in mice. Hepatology. 2011;53:1730\u201341.","journal-title":"Hepatology"},{"key":"1258_CR25","doi-asserted-by":"publisher","first-page":"e75361","DOI":"10.1371\/journal.pone.0075361","volume":"8","author":"PG Traber","year":"2013","unstructured":"Traber PG, Chou H, Zomer E, et al. Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease. PLoS One. 2013;8:e75361.","journal-title":"PLoS One"},{"key":"1258_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/hep.27117","volume":"60","author":"M Granzow","year":"2014","unstructured":"Granzow M, Schierwagen R, Klein S, et al. Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis. Hepatology. 2014;60:334\u201348.","journal-title":"Hepatology"},{"key":"1258_CR27","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1038\/emboj.2011.139","volume":"30","author":"R Rozenfeld","year":"2011","unstructured":"Rozenfeld R, Gupta A, Gagnidze K, et al. AT1R-CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. EMBO J. 2011;30:2350\u201363.","journal-title":"EMBO J"},{"key":"1258_CR28","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3892\/etm.2011.348","volume":"2","author":"T Ueno","year":"2011","unstructured":"Ueno T, Nakamura A, Nakayama H, et al. Adiponectin suppresses endoplasmic reticulum stress in nonalcoholic steatohepatitis. Exp Ther Med. 2011;2:1035\u201340.","journal-title":"Exp Ther Med"},{"key":"1258_CR29","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/hep.23421","volume":"51","author":"M Moreno","year":"2010","unstructured":"Moreno M, Chaves JF, Sancho-Bru P, et al. Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology. 2010;51:974\u201385.","journal-title":"Hepatology"},{"key":"1258_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10620-012-2314-1","volume":"58","author":"F Hong","year":"2013","unstructured":"Hong F, Chou H, Fiel MI, et al. Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in vivo. Dig Dis Sci. 2013;58:257\u201364.","journal-title":"Dig Dis Sci"},{"key":"1258_CR31","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hep.21375","volume":"44","author":"SS Choi","year":"2006","unstructured":"Choi SS, Sicklick JK, Ma Q, et al. Sustained activation of Rac 1 in hepatic stellate cells promotes liver injury and fibrosis in mice. Hepatology. 2006;44:1267\u201377.","journal-title":"Hepatology"},{"key":"1258_CR32","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/hep.26461","volume":"58","author":"B Staels","year":"2013","unstructured":"Staels B, Rubenstrunk A, Noel B, et al. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Hepatology. 2013;58:1941\u201352.","journal-title":"Hepatology"},{"key":"1258_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1164\/rccm.200706-806OC","volume":"177","author":"K Puthawala","year":"2008","unstructured":"Puthawala K, Hadjiangelis N, Jacoby SC, et al. Inhibition of integrin alpha (v) beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med. 2008;177:82\u201390.","journal-title":"Am J Respir Crit Care Med"},{"key":"1258_CR34","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/nm.3282","volume":"19","author":"NC Henderson","year":"2013","unstructured":"Henderson NC, Arnold TD, Katamura Y, et al. Targeting of alpha v integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med. 2013;19:1617\u201324.","journal-title":"Nat Med"},{"key":"1258_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nbt1396","volume":"26","author":"Y Sato","year":"2008","unstructured":"Sato Y, Murase K, Kato J, et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol. 2008;26:431\u201342.","journal-title":"Nat Biotechnol"},{"key":"1258_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nm.2208","volume":"16","author":"V Barry-Hamilton","year":"2010","unstructured":"Barry-Hamilton V, Spangler R, Marshall D, et al. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med. 2010;16:1009\u201317.","journal-title":"Nat Med"},{"key":"1258_CR37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1189\/JLB.0309135","volume":"86","author":"B Gao","year":"2009","unstructured":"Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol. 2009;86:513\u201328.","journal-title":"J Leukoc Biol"},{"key":"1258_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jhep.2009.10.030","volume":"52","author":"JB Chakraborty","year":"2010","unstructured":"Chakraborty JB, Mann DA. NF-kB signalling: Embracing complexity to achieve translation. J Hepatol. 2010;52:285\u201391.","journal-title":"J Hepatol"},{"key":"1258_CR39","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nm.3653","volume":"20","author":"SJ Forbes","year":"2014","unstructured":"Forbes SJ, Rosenthal N. Preparing the ground for tissue regeneration: from mechanism to therapy. Nat Med. 2014;20:857\u201369.","journal-title":"Nat Med"},{"key":"1258_CR40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13643-016-0277-6","volume":"5","author":"NN Than","year":"2016","unstructured":"Than NN, Tomlinson CL, Haldar D, et al. Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol. Syst Rev. 2016;5:100.","journal-title":"Syst Rev"},{"key":"1258_CR41","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1634\/stemcells.2005-0542","volume":"24","author":"S Terai","year":"2006","unstructured":"Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 2006;24:2292\u20138.","journal-title":"Stem Cells"},{"key":"1258_CR42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1089\/ten.teb.2013.0527","volume":"20","author":"S Terai","year":"2014","unstructured":"Terai S, Takami T, Yamamoto N, et al. Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells. Tissue Eng Part B Rev. 2014;20:206\u201310.","journal-title":"Tissue Eng Part B Rev"},{"key":"1258_CR43","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3727\/096368910X506863","volume":"19","author":"JK Kim","year":"2010","unstructured":"Kim JK, Park YN, Kim JS, et al. Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant. 2010;19:1237\u201346.","journal-title":"Cell Transplant"},{"key":"1258_CR44","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1089\/scd.2011.0074","volume":"20","author":"T Saito","year":"2011","unstructured":"Saito T, Okumoto K, Haga H, et al. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev. 2011;20:1503\u201310.","journal-title":"Stem Cells Dev"},{"key":"1258_CR45","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1634\/stemcells.2005-0629","volume":"24","author":"MY Gordon","year":"2006","unstructured":"Gordon MY, Levicar N, Pai M, et al. Characterization and clinical application of human CD34+ stem\/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 2006;24:1822\u201330.","journal-title":"Stem Cells"},{"issue":"Suppl 1","key":"1258_CR46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2184.2008.00491.x","volume":"41","author":"N Levicar","year":"2008","unstructured":"Levicar N, Pai M, Habib NA, et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif. 2008;41(Suppl 1):115\u201325.","journal-title":"Cell Prolif"},{"key":"1258_CR47","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.transproceed.2008.03.111","volume":"40","author":"AA Khan","year":"2008","unstructured":"Khan AA, Parveen N, Mahaboob VS, et al. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. Transplant Proc. 2008;40:1140\u20134.","journal-title":"Transplant Proc"},{"key":"1258_CR48","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1111\/j.1572-0241.2008.01993.x","volume":"103","author":"M Pai","year":"2008","unstructured":"Pai M, Zacharoulis D, Milicevic MN, et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol. 2008;103:1952\u20138.","journal-title":"Am J Gastroenterol"},{"key":"1258_CR49","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/14653240802129901","volume":"10","author":"Y Han","year":"2008","unstructured":"Han Y, Yan L, Han G, et al. Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy. Cytotherapy. 2008;10:390\u20136.","journal-title":"Cytotherapy"},{"key":"1258_CR50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/hep.22317","volume":"48","author":"L Spahr","year":"2008","unstructured":"Spahr L, Lambert JF, Rubbia-Brandt L, et al. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology. 2008;48:221\u20139.","journal-title":"Hepatology"},{"key":"1258_CR51","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.3748\/wjg.v16.i42.5297","volume":"16","author":"H Salama","year":"2010","unstructured":"Salama H, Zekri AR, Bahnassy AA, et al. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol. 2010;16:5297\u2013305.","journal-title":"World J Gastroenterol"},{"key":"1258_CR52","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3727\/096368910X514314","volume":"19","author":"H Salama","year":"2010","unstructured":"Salama H, Zekri AR, Zern M, et al. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Cell Transplant. 2010;19:1475\u201386.","journal-title":"Cell Transplant"},{"issue":"505\u2013512","key":"1258_CR53","first-page":"e1","volume":"142","author":"V Garg","year":"2012","unstructured":"Garg V, Garg H, Khan A, et al. Granulocyte colony\u2013stimulating factor mobilizes CD34+ cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology. 2012;142(505\u2013512):e1.","journal-title":"Gastroenterology"},{"issue":"1362\u201370","key":"1258_CR54","first-page":"e7","volume":"148","author":"CK Kedarisetty","year":"2015","unstructured":"Kedarisetty CK, Anand L, Bhardwaj A, et al. Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis. Gastroenterology. 2015;148(1362\u201370):e7.","journal-title":"Gastroenterology"},{"key":"1258_CR55","doi-asserted-by":"publisher","first-page":"e007700","DOI":"10.1136\/bmjopen-2015-007700","volume":"5","author":"A King","year":"2015","unstructured":"King A, Barton D, Beard HA, et al. REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial. BMJ Open. 2015;5:e007700.","journal-title":"BMJ Open"},{"key":"1258_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015;17:11\u201322.","journal-title":"Cell Stem Cell"},{"key":"1258_CR57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.21704","volume":"46","author":"A Banas","year":"2007","unstructured":"Banas A, Teratani T, Yamamoto Y, et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology. 2007;46:219\u201328.","journal-title":"Hepatology"},{"key":"1258_CR58","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/hep.26470","volume":"58","author":"A Seki","year":"2013","unstructured":"Seki A, Sakai Y, Komura T, et al. Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model. Hepatology. 2013;58:1133\u201342.","journal-title":"Hepatology"},{"key":"1258_CR59","doi-asserted-by":"publisher","first-page":"725","DOI":"10.5966\/sctm.2012-0034","volume":"1","author":"M Shi","year":"2012","unstructured":"Shi M, Zhang Z, Xu R, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012;1:725\u201331.","journal-title":"Stem Cells Transl Med"},{"issue":"Suppl 2","key":"1258_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","volume":"27","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Lin H, Shi M, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol. 2012;27(Suppl 2):112\u201320.","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"1258_CR61","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/jgh.12029","volume":"28","author":"L Wang","year":"2013","unstructured":"Wang L, Li J, Liu H, et al. Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 2013;28(Suppl 1):85\u201392.","journal-title":"J Gastroenterol Hepatol"},{"key":"1258_CR62","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1089\/scd.2013.0500","volume":"23","author":"L Wang","year":"2014","unstructured":"Wang L, Han Q, Chen H, et al. Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis. Stem Cells Dev. 2014;23:2482\u20139.","journal-title":"Stem Cells Dev"},{"key":"1258_CR63","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1242\/dev.134189","volume":"143","author":"PT Sharpe","year":"2016","unstructured":"Sharpe PT. Dental mesenchymal stem cells. Development. 2016;143:2273\u201380.","journal-title":"Development"},{"key":"1258_CR64","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7:e47559.","journal-title":"PLoS One"},{"key":"1258_CR65","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nature13071","volume":"508","author":"Y Omatsu","year":"2014","unstructured":"Omatsu Y, Seike M, Sugiyama T, et al. Foxc 1 is a critical regulator of haematopoietic stem\/progenitor cell niche formation. Nature. 2014;508:536\u201340.","journal-title":"Nature"},{"key":"1258_CR66","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni.3002","volume":"15","author":"Y Wang","year":"2014","unstructured":"Wang Y, Chen X, Cao W, et al. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014;15:1009\u201316.","journal-title":"Nat Immunol"},{"key":"1258_CR67","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/pmic.201200373","volume":"13","author":"T Katsuda","year":"2013","unstructured":"Katsuda T, Kosaka N, Takeshita F, et al. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics. 2013;13:1637\u201353.","journal-title":"Proteomics"},{"key":"1258_CR68","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1517\/14712598.2016.1170804","volume":"16","author":"A Monsel","year":"2016","unstructured":"Monsel A, Zhu YG, Gudapati V, et al. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Expert Opin Biol Ther. 2016;16:859\u201371.","journal-title":"Expert Opin Biol Ther"},{"key":"1258_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11626-015-9948-1","volume":"52","author":"CM Park","year":"2016","unstructured":"Park CM, Kim MJ, Kim SM, et al. Umbilical cord mesenchymal stem cell-conditioned media prevent muscle atrophy by suppressing muscle atrophy-related proteins and ROS generation. In Vitro Cell Dev Biol Anim. 2016;52:68\u201376.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"1258_CR70","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.3748\/wjg.v13.i24.3359","volume":"13","author":"M Mohamadnejad","year":"2007","unstructured":"Mohamadnejad M, Namiri M, Bagheri M, et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol. 2007;13:3359\u201363.","journal-title":"World J Gastroenterol"},{"key":"1258_CR71","first-page":"459","volume":"10","author":"M Mohamadnejad","year":"2007","unstructured":"Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med. 2007;10:459\u201366.","journal-title":"Arch Iran Med"},{"key":"1258_CR72","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","volume":"21","author":"P Kharaziha","year":"2009","unstructured":"Kharaziha P, Hellstrom PM, Noorinayer B, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I\u2013II clinical trial. Eur J Gastroenterol Hepatol. 2009;21:1199\u2013205.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1258_CR73","first-page":"135","volume":"6","author":"MMS El-Ansary","year":"2010","unstructured":"El-Ansary MMS, Abdel-Aziz I, Abdel-Hamid S. Phase I trial: mesenchymal stem cells transplantation in end stage liver disease. J Am Sci. 2010;6:135\u201344.","journal-title":"J Am Sci"},{"key":"1258_CR74","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/MEG.0b013e3283488b00","volume":"23","author":"ME Amer","year":"2011","unstructured":"Amer ME, El-Sayed SZ, El-Kheir WA, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol. 2011;23:936\u201341.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1258_CR75","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/hep.24434","volume":"54","author":"L Peng","year":"2011","unstructured":"Peng L, Xie DY, Lin BL, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology. 2011;54:820\u20138.","journal-title":"Hepatology"},{"key":"1258_CR76","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s12015-011-9322-y","volume":"8","author":"M El-Ansary","year":"2012","unstructured":"El-Ansary M, Abdel-Aziz I, Mogawer S, et al. Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev. 2012;8:972\u201381.","journal-title":"Stem Cell Rev"},{"key":"1258_CR77","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/liv.12228","volume":"33","author":"M Mohamadnejad","year":"2013","unstructured":"Mohamadnejad M, Alimoghaddam K, Bagheri M, et al. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver Int. 2013;33:1490\u20136.","journal-title":"Liver Int"},{"key":"1258_CR78","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ctr.12179","volume":"27","author":"MA Amin","year":"2013","unstructured":"Amin MA, Sabry D, Rashed LA, et al. Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study. Clin Transplant. 2013;27:607\u201312.","journal-title":"Clin Transplant"},{"key":"1258_CR79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/liv.12218","volume":"34","author":"YO Jang","year":"2014","unstructured":"Jang YO, Kim YJ, Baik SK, et al. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. Liver Int. 2014;34:33\u201341.","journal-title":"Liver Int"},{"key":"1258_CR80","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/scrt459","volume":"5","author":"H Salama","year":"2014","unstructured":"Salama H, Zekri AR, Medhat E, et al. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease. Stem Cell Res Ther. 2014;5:70.","journal-title":"Stem Cell Res Ther"},{"key":"1258_CR81","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1111\/jgh.12653","volume":"29","author":"L Xu","year":"2014","unstructured":"Xu L, Gong Y, Wang B, et al. Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg\/Th17 cells. J Gastroenterol Hepatol. 2014;29:1620\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"1258_CR82","first-page":"217","volume":"2","author":"SP Lukashyk","year":"2014","unstructured":"Lukashyk SP, Tsyrkunov VM, Isaykina YI, et al. Mesenchymal bone marrow-derived stem cells transplantation in patients with HCV related liver cirrhosis. J Clin Transl Hepatol. 2014;2:217\u201321.","journal-title":"J Clin Transl Hepatol"},{"key":"1258_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28693","author":"KT Suk","year":"2016","unstructured":"Suk KT, Yoon JH, Kim MY, et al. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial. Hepatology. 2016. doi: 10.1002\/hep.28693 .","journal-title":"Hepatology."},{"key":"1258_CR84","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1478-3231.2009.02031.x","volume":"29","author":"KH Jung","year":"2009","unstructured":"Jung KH, Shin HP, Lee S, et al. Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model. Liver Int. 2009;29:898\u2013909.","journal-title":"Liver Int"},{"key":"1258_CR85","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.lfs.2009.08.003","volume":"85","author":"YJ Chang","year":"2009","unstructured":"Chang YJ, Liu JW, Lin PC, et al. Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci. 2009;85:517\u201325.","journal-title":"Life Sci"},{"key":"1258_CR86","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4174\/jkss.2011.81.3.176","volume":"81","author":"SJ Kim","year":"2011","unstructured":"Kim SJ, Park KC, Lee JU, et al. Therapeutic potential of adipose tissue-derived stem cells for liver failure according to the transplantation routes. J Korean Surg Soc. 2011;81:176\u201386.","journal-title":"J Korean Surg Soc"},{"key":"1258_CR87","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00441-013-1727-2","volume":"354","author":"H Tanimoto","year":"2013","unstructured":"Tanimoto H, Terai S, Taro T, et al. Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow. Cell Tissue Res. 2013;354:717\u201328.","journal-title":"Cell Tissue Res"},{"key":"1258_CR88","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12876-014-0198-6","volume":"14","author":"YO Jang","year":"2014","unstructured":"Jang YO, Kim MY, Cho MY, et al. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model. BMC Gastroenterol. 2014;14:198.","journal-title":"BMC Gastroenterol"},{"key":"1258_CR89","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2015.03.039","volume":"63","author":"F Tacke","year":"2015","unstructured":"Tacke F, Trautwein C. Mechanisms of liver fibrosis resolution. J Hepatol. 2015;63:1038\u20139.","journal-title":"J Hepatol"},{"key":"1258_CR90","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1172\/JCI200522675","volume":"115","author":"JS Duffield","year":"2005","unstructured":"Duffield JS, Forbes SJ, Constandinou CM, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 2005;115:56\u201365.","journal-title":"J Clin Invest"},{"key":"1258_CR91","doi-asserted-by":"publisher","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","volume":"109","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran P, Pellicoro A, Vernon MA, et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci U S A. 2012;109:E3186\u201395.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1258_CR92","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1073\/pnas.1302168110","volume":"110","author":"TG Bird","year":"2013","unstructured":"Bird TG, Lu WY, Boulter L, et al. Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc Natl Acad Sci U S A. 2013;110:6542\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1258_CR93","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nm.2667","volume":"18","author":"L Boulter","year":"2012","unstructured":"Boulter L, Govaere O, Bird TG, et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. 2012;18:572\u20139.","journal-title":"Nat Med"},{"key":"1258_CR94","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1172\/JCI66026","volume":"123","author":"L Boulter","year":"2013","unstructured":"Boulter L, Lu WY, Forbes SJ. Differentiation of progenitors in the liver: a matter of local choice. J Clin Invest. 2013;123:1867\u201373.","journal-title":"J Clin Invest"},{"key":"1258_CR95","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jcyt.2015.07.016","volume":"17","author":"JK Moore","year":"2015","unstructured":"Moore JK, Mackinnon AC, Wojtacha D, et al. Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study. Cytotherapy. 2015;17:1604\u201316.","journal-title":"Cytotherapy"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1258-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-016-1258-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1258-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T07:46:34Z","timestamp":1718783194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-016-1258-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,8]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1258"],"URL":"https:\/\/doi.org\/10.1007\/s00535-016-1258-1","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,8]]},"assertion":[{"value":"25 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Shuji Terai received a research grant from Rohto Pharmaceutical, Interstem, and Nippon Shinyaku Co.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}